BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1284885)

  • 1. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
    Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
    Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
    Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
    Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry in the diagnosis of peritoneal carcinomatosis.
    Both CT; de Mattos AA; Neumann J; Reis MD
    Am J Gastroenterol; 2001 May; 96(5):1605-9. PubMed ID: 11374707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic paracentesis. A two-step approach.
    Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
    Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools for the diagnosis of peritoneal carcinomatosis?
    Koch TR
    Am J Gastroenterol; 2002 Aug; 97(8):2133-4. PubMed ID: 12190190
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of fibronectin in diagnosis of malignant ascites.
    Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
    J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE; Fasakin Y; El-Serag HB
    Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen (CEA) in ascites].
    Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D
    Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibronectin in the ascitic fluid: its diagnostic significance].
    Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
    Gerbes AL; Xie YN; Mezger J; Jüngst D
    Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
    Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
    Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics.
    Lu CW; Wang SS; Lee SD; Tsai YT; Lee FY; Shiesh SC; Wu SL; Lu RH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):350-6. PubMed ID: 1649678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of cholinesterase determination in ascitic fluid in the differential diagnosis of ascites].
    Vázquez Rodríguez de Alba J; Ena Muñoz J; Such Ronda J; Almenar Bonet MV; Graells Ferrer ML
    An Med Interna; 2000 Jul; 17(7):351-5. PubMed ID: 10981331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.
    Catarino RM; Lopes JD; Forones NM; Parise ER
    Braz J Med Biol Res; 2005 Feb; 38(2):271-6. PubMed ID: 15785839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.
    Gulyás M; Kaposi AD; Elek G; Szollár LG; Hjerpe A
    J Clin Pathol; 2001 Nov; 54(11):831-5. PubMed ID: 11684715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The laparoscopic evaluation of ascites.
    Inadomi JM; Kapur S; Kinkhabwala M; Cello JP
    Gastrointest Endosc Clin N Am; 2001 Jan; 11(1):79-91. PubMed ID: 11175976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.